Bharat Biotech in-licences GSK's Shigella vaccine candidate |...

Dununu.com Dununu

Patrocinado

Bharat Biotech in-licences GSK's Shigella vaccine candidate

RSS Feed Business

Postado

73

Bharat Biotech has in-licensed GSK's Shigella vaccine candidate, altSonflex1-2-3, aimed at combating Shigellosis in young children in low- and middle-income countries. Following promising early-stage trials by GSK, Bharat Biotech will advance the vaccine through Phase-III trials, regulatory processes, and large-scale production. This collaboration strengthens Bharat Biotech's portfolio of vaccines against diarrheal infections.

Read Full Article

Faça Login para curtir, compartilhar e comentar!

'It's only been 8 hours': Donald Trump threatens to impose 'secondary sanctions' on India; hints at possible ban on China

Amidst deepening India-Russia oil ties, President Trump has escalated sanctions against New Delhi...

Por 0 2

UCLA faces uncertainty as Trump suspends $584 million in federal grants over civil rights probe

Por 0 8

New school year opens under cloud of deportation anxiety, keeping immigrant students home across the US

Por 0 8

Trump slaps extra 25% tariff on Indian goods, ties with New Delhi deteriorate further

WASHINGTON DC: U.S. President Donald Trump on Wednesday announced an additional 25% tariff...

Por 0 14

Heavy rainfall likely in Koshi, Bagmati, and Gandaki

KATHMANDU: Weather conditions are set to intensify today, with the Department of Hydrology and...

Por 0 20